Peritumoral portal enhancement during transarterial chemoembolization: a potential prognostic factor for patients with hepatocellular carcinoma.

Sofi Sennefelt NymanAngeliki Dimopoulou CreusenUlf JohnssonFredrik RorsmanJohan Vessby Charlotte Ebeling Barbier

Published in: Acta radiologica (Stockholm, Sweden : 1987) (2021)

TACE was effective and safe in patients with intermediate stage HCC. Patients with PPLE during TACE had better tumor response and longer survival than those without PPLE. Severe adverse events occurred more often in patients with larger tumors.

Keyphrases

prognostic factors
radiofrequency ablation
early onset
liver metastases
free survival
human health
climate change